10-Q Filing

AGILON HEALTH, INC. CIK: 1831097 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-014787`
Period End Date	20220630
Filing Date	20220804
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	agl-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 104 Cash Flow Statement 59 Stockholders Equity 32 Comprehensive Income 20

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$668.57M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04B	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$14.78M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$15.09M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	-	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$285.59M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$293.41M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$607.63M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$18.97M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$24.53M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.60B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	400.10M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.37B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	408.20M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.16M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	408.20M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.81M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$62.51M	USD	Point-in-time
Assets	`Assets`	$1.59B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.40M	USD	Point-in-time
Assets	`Assets`	$1.84B	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Liabilities	`Liabilities`	$737.15M	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$119.26M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$112.96M	USD	Point-in-time
Total assets	`Assets`	$1.59B	USD	Point-in-time
Total assets	`Assets`	$1.84B	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$458.04M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$239.01M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$142.05M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$112.95M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$356.96M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$605.09M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$43.40M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$40.94M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$94.30M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$91.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$737.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$494.66M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 408,204 and 400,095 shares issued and outstanding, respectively	`CommonStockValue`	$4.08M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 408,204 and 400,095 shares issued and outstanding, respectively	`CommonStockValue`	$4.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.05B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.08B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-977.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-957.68M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$513.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.10B	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.09B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-457.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-300.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.84B	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.59B	USD	Point-in-time

Income Statement 104 line items

Line Item	Tag	Value	Unit	Period
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$10.52M	USD	2 Qtrs
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$276.02M	USD	2 Qtrs
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$6.55M	USD	1 Quarter
General And Administrative Including Non Cash Stock-based Compensation Expense	`AllocatedShareBasedCompensationExpense`	$274.55M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$498.96M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$670.13M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$912.06M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.32B	USD	2 Qtrs
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$442.48M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.15B	USD	2 Qtrs
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$802.84M	USD	2 Qtrs
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$587.14M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$33.69M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$49.08M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$57.35M	USD	2 Qtrs
Other medical expenses	`OtherMedicalExpenses`	$93.85M	USD	2 Qtrs
General and administrative (including noncash stock-based compensation expense of $6,553, $274,548, $10,523, and $276,020, respectively)	`GeneralAndAdministrativeExpense`	$355.34M	USD	2 Qtrs
General and administrative (including noncash stock-based compensation expense of $6,553, $274,548, $10,523, and $276,020, respectively)	`GeneralAndAdministrativeExpense`	$317.56M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $6,553, $274,548, $10,523, and $276,020, respectively)	`GeneralAndAdministrativeExpense`	$51.92M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $6,553, $274,548, $10,523, and $276,020, respectively)	`GeneralAndAdministrativeExpense`	$91.76M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.58M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$6.42M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.04M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$7.01M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$691.19M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.22B	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$797.32M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.35B	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-21.05M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-298.36M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-310.48M	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-21.80M	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$2.97M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$9.27M	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$7.00M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$4.30M	USD	2 Qtrs
Gain (loss) on lease terminations	`GainLossOnLeaseTerminations`	$-5.46M	USD	1 Quarter
Gain (loss) on lease terminations	`GainLossOnLeaseTerminations`	-	USD	2 Qtrs
Gain (loss) on lease terminations	`GainLossOnLeaseTerminations`	$-5.46M	USD	2 Qtrs
Gain (loss) on lease terminations	`GainLossOnLeaseTerminations`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$1.82M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.50M	USD	1 Quarter
Interest expense	`InterestExpense`	$945.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.44M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-310.61M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-20.46M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-296.89M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-19.80M	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$451.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$435.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$509.00K	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$580.00K	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-297.33M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-21.04M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-20.31M	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-311.06M	USD	2 Qtrs
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.55M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$321.00K	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-2.90M	USD	2 Qtrs
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$750.00K	USD	2 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$129.00K	USD	2 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$65.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$14.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$14.00K	USD	2 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.61M	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$736.00K	USD	2 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-3.03M	USD	2 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$307.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-20.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-314.09M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-19.58M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-298.94M	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$82.00K	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$169.00K	USD	2 Qtrs
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$96.00K	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$157.00K	USD	2 Qtrs
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-19.42M	USD	2 Qtrs
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-20.65M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-298.85M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-313.92M	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Basic Share	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.05	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Basic Share	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.88	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Basic Share	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.05	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Basic Share	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.79	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.05	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.88	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.05	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.79	USD	1 Quarter
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	2 Qtrs
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	2 Qtrs
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	2 Qtrs
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	2 Qtrs
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	377.44M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	407.34M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	404.67M	shares	2 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	351.69M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	407.34M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	377.44M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	351.69M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	404.67M	shares	2 Qtrs

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-20.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-314.09M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-19.58M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-298.94M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.09M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.42M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$10.52M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$276.02M	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.59M	USD	2 Qtrs
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.53M	USD	2 Qtrs
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$7.79M	USD	2 Qtrs
Other noncash items	`OtherNoncashIncomeExpense`	$-2.01M	USD	2 Qtrs
Other noncash items	`OtherNoncashIncomeExpense`	$-3.50M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$50.21M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$76.57M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-80.12M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-83.50M	USD	2 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.50M	USD	2 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$646.00K	USD	2 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$12.17M	USD	2 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$4.02M	USD	2 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$4.51M	USD	2 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$70.31M	USD	2 Qtrs
Investments in marketable debt securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Investments in marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$285.08M	USD	2 Qtrs
Proceeds from repayment of loans receivable and other	`ProceedsFromCollectionOfLoansReceivable`	$1.28M	USD	2 Qtrs
Proceeds from repayment of loans receivable and other	`ProceedsFromCollectionOfLoansReceivable`	$4.28M	USD	2 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-2.64M	USD	2 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$500.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-305.48M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-76.34M	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromStockOptionsExercised`	$1.17B	USD	2 Qtrs
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$551.00K	USD	2 Qtrs
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$20.32M	USD	2 Qtrs
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	2 Qtrs
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.50M	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$118.65M	USD	2 Qtrs
Equity and debt issuance costs and other	`PaymentOfFinancingAndStockIssuanceCosts`	$9.77M	USD	2 Qtrs
Equity and debt issuance costs and other	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.14B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.82M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$986.62M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-371.16M	USD	2 Qtrs
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$683.66M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$1.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`RestrictedCashAndCashEquivalents`	$683.66M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$1.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`RestrictedCashAndCashEquivalents`	$683.66M	USD	Point-in-time

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	408.20M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-20.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-314.09M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-19.58M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-298.94M	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$551.00K	USD	2 Qtrs
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.32M	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$386.00K	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$21.07M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$513.00K	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$513.00K	USD	1 Quarter
Shares withheld related to net share settlement	`SharesPaidForTaxWithholdingForShareBasedCompensation`	758,000.00	shares	1 Quarter
Shares withheld related to net share settlement	`SharesPaidForTaxWithholdingForShareBasedCompensation`	758,000.00	shares	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.52M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.55M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.08M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.55M	USD	2 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-298.24M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	400.10M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	408.20M	shares	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-20.73M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-314.09M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-19.58M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-298.94M	USD	1 Quarter
Net unrealized gain (loss) on marketable debt securities, net of tax	`MarketableSecuritiesUnrealizedGainLoss`	$513.00K	USD	2 Qtrs
Net unrealized gain (loss) on marketable debt securities, net of tax	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	2 Qtrs
Net unrealized gain (loss) on marketable debt securities, net of tax	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Net unrealized gain (loss) on marketable debt securities, net of tax	`MarketableSecuritiesUnrealizedGainLoss`	$513.00K	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-20.22M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-19.06M	USD	2 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-314.09M	USD	2 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-298.94M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-82.00K	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-157.00K	USD	2 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-169.00K	USD	2 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-96.00K	USD	1 Quarter
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-313.92M	USD	2 Qtrs
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-18.91M	USD	2 Qtrs
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-298.85M	USD	1 Quarter
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-20.14M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.